BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 33562446)

  • 21. Understanding Cannabis-Based Therapeutics in Sports Medicine.
    Maurer GE; Mathews NM; Schleich KT; Slayman TG; Marcussen BL
    Sports Health; 2020; 12(6):540-546. PubMed ID: 32936058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis in liver disorders: a friend or a foe?
    Goyal H; Rahman MR; Perisetti A; Shah N; Chhabra R
    Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1283-1290. PubMed ID: 30169449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets.
    Salami SA; Martinelli F; Giovino A; Bachari A; Arad N; Mantri N
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32899626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicological properties of Δ9-tetrahydrocannabinol and cannabidiol.
    Černe K
    Arh Hig Rada Toksikol; 2020 Mar; 71(1):1-11. PubMed ID: 32597140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence.
    Jensen B; Chen J; Furnish T; Wallace M
    Curr Pain Headache Rep; 2015 Oct; 19(10):50. PubMed ID: 26325482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive and Negative Effects of Cannabis and Cannabinoids on Health.
    Cohen K; Weizman A; Weinstein A
    Clin Pharmacol Ther; 2019 May; 105(5):1139-1147. PubMed ID: 30703255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic potential of cannabinoids in combination cancer therapy.
    Malhotra P; Casari I; Falasca M
    Adv Biol Regul; 2021 Jan; 79():100774. PubMed ID: 33422460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. State of the science: cannabis and cannabinoids in palliative medicine-the potential.
    Roychoudhury P; Kapoor AK; Walsh D; Cortes H; Clarke H
    BMJ Support Palliat Care; 2021 Sep; 11(3):299-302. PubMed ID: 33903260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid signaling in health and disease.
    Lu Y; Anderson HD
    Can J Physiol Pharmacol; 2017 Apr; 95(4):311-327. PubMed ID: 28263083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
    Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Changing Drug Culture: Medical and Recreational Marijuana.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():11-7. PubMed ID: 26881768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG
    Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
    Sarris J; Sinclair J; Karamacoska D; Davidson M; Firth J
    BMC Psychiatry; 2020 Jan; 20(1):24. PubMed ID: 31948424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
    Smith PF
    Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse Effects of Recreational and Medical Cannabis.
    Urits I; Charipova K; Gress K; Li N; Berger AA; Cornett EM; Kassem H; Ngo AL; Kaye AD; Viswanath O
    Psychopharmacol Bull; 2021 Jan; 51(1):94-109. PubMed ID: 33897066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Pharmacology of Phytocannabinoids.
    Turner SE; Williams CM; Iversen L; Whalley BJ
    Prog Chem Org Nat Prod; 2017; 103():61-101. PubMed ID: 28120231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?
    Khalid S; Almalki FA; Hadda TB; Bader A; Abu-Izneid T; Berredjem M; Elsharkawy ER; Alqahtani AM
    Curr Pharm Des; 2021; 27(13):1564-1578. PubMed ID: 33267756
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.